Lycia Therapeutics
Biotechnology, 681 Gateway BLVD Fl 3, South San Francisco, California, 94080, United States, 11-50 Employees
Who is LYCIA THERAPEUTICS
Lycia is a Series B biotech company building upon the novel platform developed by academic founder Professor Carolyn Bertozzi at Stanford University to develop LYTAC (lysosomal targeting ...
Read More
-
Headquarters: 681 Gateway BLVD Fl 3, South San Francisco, California, 94080, United States
-
Date Founded: 2020
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 28
|
NAICS Code: 32 |
Show More
Does something look wrong? Fix it. | View contact records from LYCIA THERAPEUTICS
Lycia Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Lycia Therapeutics
Answer: Lycia Therapeutics's headquarters are located at 681 Gateway BLVD Fl 3, South San Francisco, California, 94080, United States
Answer: Lycia Therapeutics's official website is https://lyciatx.com
Answer: Lycia Therapeutics's revenue is $1 Million to $5 Million
Answer: Lycia Therapeutics's SIC: 28
Answer: Lycia Therapeutics's NAICS: 32
Answer: Lycia Therapeutics has 11-50 employees
Answer: Lycia Therapeutics is in Biotechnology
Answer: Lycia Therapeutics contact info: Phone number: Website: https://lyciatx.com
Answer: Lycia is a Series B biotech company building upon the novel platform developed by academic founder Professor Carolyn Bertozzi at Stanford University to develop LYTAC (lysosomal targeting chimera) protein degraders that harness the cells lysosomal trafficking and degradation pathway to target both soluble and membrane-bound extracellular proteins. Applications of the LYTAC platform include: targeting challenging membrane proteins, clearing pathogenic immune complexes in circulation and depleting antibodies to specific antigens of interest. The platform can potentially deliver next-generation therapeutics to address a range of difficult-to-treat diseases, including cancer and autoimmune diseases.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Powered by
Sign in to CIENCE GO Data to uncover contact details
Free credits every month